New Stock News | Shenyan Intelligence will submit its financial reports to the Hong Kong Stock Exchange for the second time this year.
According to the disclosure of the Hong Kong Stock Exchange on December 1st, Beijing Shenyan Intelligent Technology Co., Ltd. (Shenyan Intelligent) submitted an application to the Hong Kong Stock Exchange main board, with Guotai Junan International as the sole sponsor.
According to the disclosure on December 1st by the Hong Kong Stock Exchange, Beijing Shenyan Intelligent Technology Co., Ltd. (Shenyan Intelligent) has submitted its application to the Hong Kong Stock Exchange main board, with ICBC International as the exclusive sponsor. This is the second time the company has submitted their application this year. The prospectus shows that the company is a Chinese decision-making AI technology company, focusing on AI applications in marketing and sales scenarios. According to Frost & Sullivan data, based on projected revenue for 2024, the company ranks first in the Chinese marketing and sales decision-making AI application market with a market share of 2.6%. In the overall decision-making AI application market in China, the company ranks fourth based on projected revenue for 2024, with a market share of 1.6%.
During the reporting period of previous achievements, the company has provided decision-making AI applications with a strategic focus on marketing and sales scenarios, including intelligent advertising placement and intelligent data management. These applications include two flagship platforms, AlphaDesk and AlphaData.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






